How can govt build trust on Covid-19 vaccine?

A total of 3,81,305 beneficiaries have so far been vaccinated for COVID-19 and 580 adverse events following immunisation were reported in the country till now, the Union health ministry said on Monday.

Meanwhile, there has been concerns over the grant of permission for the restricted use of Covaxin. The day India began its Covid-19 vaccination drive across the country, doctors of Delhi's premier Ram Manohar Lohia Hospital expressed apprehension regarding Bharat Biotech vaccine Covaxin and said they would prefer Covishield vaccine of Serum Institute of India.

So, how can govt build trust on Covid vaccine? What explains mixed response to vaccine drive? And should drive be extended to frontline workers? Watch as experts share their thoughts.